Log in to search using one of your social media accounts:

 

ACP, CDC Issue Guidance on Hep B Screening, Treatment
The American College of Physicians and CDC released a clinical guideline on hepatitis B virus infection that offers recommendations on vaccination, screening and linking patients to care. (Source: AAFP News)
Source: AAFP News - November 29, 2017 Category: Primary Care Source Type: news

Uganda:Grains Carry Cancerous Substances, Scientists Warn
[Monitor] Kampala -Makerere University researchers have warned that Ugandans are at risk of contracting liver cancer and hepatitis B after several food crops have been found to contain high levels of fungi-produced toxic chemicals called aflatoxins. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 29, 2017 Category: African Health Source Type: news

HCC in Chronic HBV vs Chronic HCV After Virologic Response HCC in Chronic HBV vs Chronic HCV After Virologic Response
Does the achievement of virologic response modify the risk of hepatocellular carcinoma differently in patients with chronic hepatitis B as compared to those with chronic hepatitis C?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Elevated Liver Cancer, Death Rates With Chronic HBV Elevated Liver Cancer, Death Rates With Chronic HBV
Patients with immune-tolerant-phase chronic hepatitis B virus (HBV) infection, who are usually not considered for treatment, face an increased risk of hepatocellular carcinoma (HCC) and death, compared with treated immune-active-phase patients, researchers from Korea report.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 22, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

ACP and CDC issue recommendations for hepatitis B screening, vaccination, and care
(American College of Physicians) Reducing chronic hepatitis B infections by screening at-risk adults, increasing hepatitis B vaccination rates, and linking infected persons to care is a public health priority, the American College of Physicians and the Centers for Disease Control and Prevention advise in a new paper published today in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2017 Category: Cancer & Oncology Source Type: news

Global Routine Vaccination Coverage, 2016
Global coverage with the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine, the third dose of polio vaccine, and first dose of measles. Among new or underused vaccines, global coverage increased during 2010-2016 for completed vaccine series against rotavirus (8% to 25%), Streptococcus pneumoniae (11% to 42%), rubella (35% to 47%), Haemophilus influenzae type B (42% to 70%) and hepatitis B vaccine (74% to 84%). containing vaccine coverage has remained unchanged at 84%-86% since 2010. (Source: PHPartners.org)
Source: PHPartners.org - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Heplisav B (Hepatitis B Vaccine Solution for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Preventing Perinatal Transmission of Hepatitis B Preventing Perinatal Transmission of Hepatitis B
Dr William Balistreri surveys the latest guidelines and studies aiming to improve maternal and neonatal outcomes.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2017 Category: Consumer Health News Tags: Gastroenterology Expert Column Source Type: news

Health Center Strategies to Advance Prevention of Perinatal Transmission of Hepatitis B Webinar
December 6, 2017 3:00-4:00pm. No registration required. Join on day of session. Call-in: 888-603-9609 Passcode: 8184117 (Source: PHPartners.org)
Source: PHPartners.org - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up
(Reuters) - Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the drug. (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults
BERKELEY, CA -- (Marketwired) -- November 9, 2017 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

Promising new drug for Hep B tested at Texas Biomedical Research Institute
(Texas Biomedical Research Institute) Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 7, 2017 Category: Infectious Diseases Source Type: news

Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016
Coverage with most recommended vaccines remained stable and high in 2016; coverage was ≥90% for polio, measles, mumps, and rubella, varicella, and hepatitis B vaccines, and lowest (61%-74%) for hepatitis A, the birth dose of hepatitis B, and rotavirus vaccines, and the combined 7-vaccine series. (Source: PHPartners.org)
Source: PHPartners.org - November 3, 2017 Category: International Medicine & Public Health Source Type: news

National Viral Hepatitis Progress Report
Report highlighting the nation's progress toward reducing the burden of hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections. (Source: PHPartners.org)
Source: PHPartners.org - November 1, 2017 Category: International Medicine & Public Health Source Type: news

Ahead of Brazil Summit, UN reports 3 million people now have access to hepatitis C cure
A record 3 million people obtained treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016, the United Nations health agency reported Tuesday, the eve of the World Hepatitis Summit in Brazil, highlighting increasing momentum in the global response to the viral disease. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Ahead of Brazil Summit, UN reports three million people now have access to hepatitis C cure
A record three million people obtained treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016, the United Nations health agency reported Tuesday, the eve of the World Hepatitis Summit in Brazil, highlighting increasing momentum in the global response to the viral disease. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Close to 3 million people access hepatitis C cure
(Source: WHO news)
Source: WHO news - October 31, 2017 Category: International Medicine & Public Health Tags: hepatitis [subject], jaundice, hepatitis a, hepatitis b, hepatitis c, hepatitis e, hepatitis [subject], jaundice, hepatitis a, hepatitis b, hepatitis c, hepatitis e, Press release [doctype] Source Type: news

Mayo Clinic Q and A: Safeguarding the blood supply
DEAR MAYO CLINIC: I have given blood for 25 years, but just recently, I received a letter saying I could not give blood for six months because of an inconclusive hepatitis B test. What does this mean? Will I be able to give blood in the future? ANSWER: The notification you received means the test [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 31, 2017 Category: Databases & Libraries Source Type: news

TAF Bests TDF for Hepatitis B Treatment (CME/CE)
(MedPage Today) -- Less BMD decline with newer drug (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - October 23, 2017 Category: Consumer Health News Source Type: news

Aspirin may reduce risk for liver cancer in hepatitis B patients, study says
Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 20, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Daily aspirin could ward off liver cancer
Taking aspirin every day could help to lower the risk of liver cancer for patients infected with hepatitis B, a new study suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 20, 2017 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
FRIDAY, Oct. 20, 2017 -- Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
Title: Can Aspirin Stop Liver Cancer in Hepatitis B Patients?Category: Health NewsCreated: 10/20/2017 12:00:00 AMLast Editorial Review: 10/20/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 20, 2017 Category: Nutrition Source Type: news

Bucks biopharm firm signs licensing deal with California onco-immunology company
Arbutus BioPharma Corp., a Bucks County company developing treatments to cure hepatitis B infections, has entered into a collaboration and licensing deal with a California biopharmaceutical company developing personalized cancer immunotherapies. Under the terms of this license agreement, Gritstone Oncology of Emeryville, Calif., gets worldwide access to Arbutus’ portfolio of proprietary and clinically validated lipid nanoparticle [LNP] products and associated intellectual property. Gritstone will… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 18, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

Alnylam to partner with Scangos-led biotech on infectious disease drugs
Vir Biotechnology, a San Francisco-based startup led by former Biogen CEO George Scangos, said Wednesday that it will work with Alnylam Pharmaceuticals to develop infectious disease treatments using the Cambridge company ’s experimental technology. Under the agreement, the companies will collaborate to develop one of Alnylam’s (Nasdaq: ALNY) potential drugs for hepatitis B, plus up to four additional treatments for infectious diseases. Alnylam will be eligible to receive over $1 billion in payments… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 18, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Alnyalm, Vir partner on RNAi-based hep B treatment
(Reuters) - Drug developer Alnylam Pharmaceuticals Inc said on Wednesday it would scrap its hepatitis B (HBV) drug development and instead work with Vir Biotechnology on a new treatment for the disease. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Alnyalm, Vir partner on RNAi-based drugs for infectious diseases
(Reuters) - Drug developer Alnylam Pharmaceuticals Inc entered into an agreement with privately held Vir Biotechnology on Wednesday to develop a new class of RNAi-based treatments for infectious diseases, including chronic hepatitis B. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Another Outbreak Related to the Nation ’s Opioid Crisis: Hepatitis C
Details the increased rates of Hepatitis C and how they correlate to the opioid epidemic by looking at West Virginia, which has the highest rates of overdose deaths and new hepatitis B and C infections in the country. Because those infected with hepatitis often do not display symptoms immediately, the disease can go untreated for years, leading eventually to end-stage liver disease. This is one among many diseases that are rising in the midst of the opioid epidemic, and although there is a treatment for it, for many it is not affordable. (May require subscription to view full article.) (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - October 17, 2017 Category: Rural Health Source Type: news

Progress in Fatty Liver and Pediatric Liver Disease Progress in Fatty Liver and Pediatric Liver Disease
New findings on nonalcoholic steatohepatitis, pediatric liver diseases, hepatitis B, and the microbiome will be among the topics tackled at the upcoming Liver Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Ethiopia: Sustaining HBV Intervention Success Stories
[Ethiopian Herald] Viral hepatitis result in a potentially life-threatening inflammation of the liver, which is characterized by complications of liver disease. Specifically, hepatitis B (HBV) and C (HCV) viruses alone cause chronic viral hepatitis which is a major global health problem responsible for 57_per cent of liver cirrhosis and 75_per cent of primary liver cancer cases, respectively. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 11, 2017 Category: African Health Source Type: news

How Common Is Hereditary Angioedema?
Discussion Angioedema is edema that is non-pitting, self-limited occurring in non-dependent areas usually in an asymmetric distribution usually on the lips, face, hands, feet, genitals and also in the bowel. It usually develops over minutes to hours (often 1-2 hours) with resolution usually within 24-48 hours. Angioedema often occurs with urticaria but 20% of patients may have isolated angioedema. Acute allergic angioedema is often caused by drugs (including antibiotics and non-steroidal anti-inflammatory drugs), foods, infections, insects, various organic substances (i.e. latex, preservatives, formaldehyde, etc.), and oth...
Source: PediatricEducation.org - October 9, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

New hexavalent vaccine including Hepatitis B for primary immunisations
From 1 October 2017, all babies born on or after 1 August 2017 will become eligible for a hexavalent vaccine which includes Hepatitis B (HepB) for their primary immunisations. (Source: NHS Networks)
Source: NHS Networks - October 9, 2017 Category: UK Health Source Type: news

Launch of National Hepatitis Strategic Framework
Honourable Minister for National Health Services and Coordination, my sister Saira Afzal Tarar; Regional Director for the WHO Eastern Mediterranean Region, my brother Mahmoud Fikri; (Source: WHO Director-General speeches)
Source: WHO Director-General speeches - October 8, 2017 Category: International Medicine & Public Health Tags: director-general [subject], director-general [subject], director-general [subject], hepatitis [subject], jaundice, hepatitis a, hepatitis b, hepatitis c, hepatitis e, Eastern Mediterranean Region [region], Pakistan [country], Speech [doctype] Source Type: news

$116M deal for Bucks County company working on hepatitis B cure
'This financing meaningfully extends Arbutus ’ operating runway.' (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 2, 2017 Category: Biotechnology Authors: John George Source Type: news

Softbank-backed Roivant to invest in hepatitis-B drug specialist
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 2, 2017 Category: Pharmaceuticals Source Type: news

Exclusive: Immunotherapy developer Dynavax explores options for Hepatitis B drug-sources
(Reuters) - Dynavax Technologies Corporation, a biotechnology company focused on drugs that harness the immune system to combat disease, is reviewing strategic options for its hepatitis B vaccine, which could include a potential sale or licensing deal, people familiar with the matter said. (Source: Reuters: Health)
Source: Reuters: Health - September 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Kenya: Alarm Over Increased Cases of Hepatitis B in Nyanza
[Nation] Medical officials are raising alarm over the prevalence of Hepatitis B in blood collected from donors in Nyanza region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 29, 2017 Category: African Health Source Type: news

‘ Collision Of 2 Crises ’ : Organ Donations Up Due To Opioid Overdose Deaths
BURLINGTON (CBS) – Doctors at Lahey Hospital told Matt Higgins a new liver was his only option for survival as chronic liver disease ravaged the Seabrook, New Hampshire man’s body. “My energy levels, I was down to nothing. I could barely walk a 100 yards without having to stop. I was jaundiced, completely yellow,” Higgins told WBZ-TV. When the call came that a liver transplant was available from a 24-year-old donor who had died from an opioid overdose, Higgins said, he did not hesitate. He immediately accepted it. “Being as sick as I was, of course I said yes. I’ll take anything that&rsq...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 26, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Confronting The Crisis Louisa Moller opioid crisis Organ Donation Source Type: news

Mexican - Americans Have Increased Risk for Liver Disease
Less likely to have hepatitis B, C virus, but more likely to be obese, have diabetes, be heavy drinkers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 26, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Nursing, Oncology, Pathology, Conference News, Source Type: news

How the Graham-Cassidy Proposal Would Hurt Communities of Color
The repeated efforts by Congress to repeal the Affordable Care Act (ACA) can feel endless — legislators keep reviving our deepest fears about how to keep our loved ones and ourselves healthy. Even though repeal was defeated in the Senate just a few months ago, there is a new bill that is as bad as, if not worse than, the previous version. Key Senators are ramming the legislation — known as Graham-Cassidy — through the chamber at warp speed. As two people who worked to make Obamacare a reality, we don’t like what we see. There will be devastating consequences for tens of millions of Americans &mdash...
Source: TIME.com: Top Science and Health Stories - September 22, 2017 Category: Consumer Health News Authors: Chris Lu, Kathy Ko Chin Tags: Uncategorized Health Care Source Type: news

Hepatitis A Has Hit Los Angeles, a Week After Sickening Hundreds in San Diego
This article originally appeared on Health.com (Source: TIME.com: Top Science and Health Stories)
Source: TIME.com: Top Science and Health Stories - September 20, 2017 Category: Consumer Health News Authors: Amanda MacMillan / Health.com Tags: Uncategorized public health Source Type: news

NPPA slashes prices of medicines for TB, cancer, hepatitis B by up to 20%
The move is expected to slash prices of some of these drugs, like Hepatitis B immunoglobulin, by as much as 20%, a senior government told ET on condition of anonymity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2017 Category: Pharmaceuticals Source Type: news

Sudan: New Cholera Cases in Central Darfur and Sennar, Hepatitis in Blue Nile
[Radio Dabanga] Zalingei / El Souki / Ed Damazin -Seven new cholera cases were recorded in the camps for the displaced near Zalingei, capital of Central Darfur, over the weekend. The isolation centre in Nierteti received four new patients. Cholera is spreading again in eastern Sudan's Sennar. Hundreds of people have reportedly been infected with Hepatitis B in Blue Nile state's Geissan. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 19, 2017 Category: African Health Source Type: news

Hepatitis B and C Viruses and Biologics Hepatitis B and C Viruses and Biologics
How should one approach patients with HBV or HCV who are candidates for biological therapy for psoriasis or other skin disorders?Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Johnson & Johnson arm halts R & D on Hepatitis C drug
​​Instead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 11, 2017 Category: Pharmaceuticals Source Type: news

Janssen to Discontinue Hepatitis C Development Program
Viral Hepatitis Research and Development to Focus on Addressing Significant Unmet Needs in Chronic Hepatitis B (Source: Johnson and Johnson)
Source: Johnson and Johnson - September 11, 2017 Category: Pharmaceuticals Source Type: news

Does Hepatitis B Cause Liver Cancer?
Title: Does Hepatitis B Cause Liver Cancer?Category: Doctor's& Expert's views on SymptomsCreated: 9/11/2017 12:00:00 AMLast Editorial Review: 9/11/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 11, 2017 Category: Cancer & Oncology Source Type: news

Guidance issued on restricted use of hep B vaccine until 2018
Nurses and midwives have been warned that a global shortage of hepatitis B vaccines is “impacting severely” on the UK and is likely to limit the country’s supply until early 2018. (Source: Nursing Times)
Source: Nursing Times - September 8, 2017 Category: Nursing Source Type: news

For Hepatitis B Patients, Aspirin Tied to Lower Risk of HCC
5 years of aspirin therapy linked to significantly lower incidence of hepatocellular carcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 1, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Infections, Internal Medicine, Oncology, Pathology, Pharmacy, Journal, Source Type: news